4-[4-(Benzyloxy)butyl]-6-methoxypyrido[2,3-b]pyrazin-3(4H)-one → 4-(4-Hydroxybutyl)-6-methoxypyrido[2,3-b]pyrazin-3(4H)-one
反応式
C([O:8][CH2:9][CH2:10][CH2:11][CH2:12][N:13]1[C:18](=[O:19])[CH:17]=[N:16][C:15]2[CH:20]=[CH:21][C:22]([O:24][CH3:25])=[N:23][C:14]1=2)C1C=CC=CC=1>C(OCC)(=O)C.ClCCl.[O-2].[O-2].[Mn+4]>[OH:8][CH2:9][CH2:10][CH2:11][CH2:12][N:13]1[C:18](=[O:19])[CH:17]=[N:16][C:15]2[CH:20]=[CH:21][C:22]([O:24][CH3:25])=[N:23][C:14]1=2参加物
実験手順
To a solution of 4-[4-(benzyloxy)butyl]-6-methoxypyrido[2,3-b]pyrazin-3(4H)-one (847 mg, 2.5 mmol) in ethyl acetate (20 ml) 20% palladium hydroxide (400 mg) was added and the catalytic hydrogenation was carried out at room temperature for 90 minutes. After removing the catalyst by filtration, the solvent was removed under reduced pressure, the obtained residue was dissolved in dichloromethane (20 ml) to which manganese dioxide (1.09 g, 12.5 mmol) was then added, and the mixture was stirred overnight at room temperature. After removing manganese dioxide by filtration, the solvent of the filtrate was removed under reduced pressure and the obtained residue was purified by silica gel column chromatography (n-hexane/ethyl acetate) to yield 548 mg (88%) of the title compound in the form of a light brown solid.
後処理
- customAfter removing the catalyst
- filtrationby filtration
- customthe solvent was removed under reduced pressure
- additionwas then added
- customAfter removing manganese dioxide
- filtrationby filtration
- customthe solvent of the filtrate was removed under reduced pressure
- customthe obtained residue was purified by silica gel column chromatography (n-hexane/ethyl acetate)
出典と根拠
- ORDレコード
- ord-12c944561158410e850bbc7500abe1e4
- 出典データセット
- uspto-grants-2015_02
- 特許番号
- US08952010B2
反応ノート
読み込み中…